Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients

Bisgin A., Yalcin A. D., Gorczynski R. M.

DIABETES RESEARCH AND CLINICAL PRACTICE, vol.96, no.3, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 96 Issue: 3
  • Publication Date: 2012
  • Doi Number: 10.1016/j.diabres.2012.02.028
  • Journal Name: DIABETES RESEARCH AND CLINICAL PRACTICE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Keywords: Soluble TRAIL, Type-2 diabetes mellitus, Non-drug using diabetic patients, RHEUMATOID-ARTHRITIS, DISEASE, CELLS, EXPRESSION, CORRELATE, SEVERITY, CANCER
  • Akdeniz University Affiliated: Yes

Abstract

We examined the association between serum sTRAIL measured by ELISA and HbA1C levels, pre/post-prandial blood glucose levels and body mass index in 22 newly diagnosed type-2 diabetic patients.